Design
Review
Authors
Loading...
May guide less frequent dosing to improve compliance; leaves open randomized confirmation of efficacy and safety.
N-acetylprocainamide has a longer half-life than procainamide, offering a pharmacokinetic rationale for less frequent dosing and potentially improved compliance in arrhythmia management.
Atkinson et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: